3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Sarcoma, Ewing
1
Osteoporotic Fractures
1
Osteoporosis
1
Neoplasms, Plasma Cell
1
Musculoskeletal Pain
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Arthralgia
1
Interventions
Zoledronic Acid
8
Vitamin D
6
Risedronic Acid
6
Calcium
6
Letrozole
4
Cholecalciferol
4
Calcium Carbonate
4
Alendronate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Nutrition Assessment
2
Goserelin
2
Estradiol
2
Denosumab
2
Calcium Gluconate
2
Aromatase Inhibitors
2
Absorptiometry, Photon
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Technetium
1
Raloxifene Hydrochloride
1
Progesterone
1
Parathyroid Hormone-Related Protein
1
Parathyroid Hormone
1
Lysine Acetyltransferase 5
1
Ibandronic Acid
1
Hormone Replacement Therapy
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteoporosis
×
Diphosphonates
×
Clear all
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled